【svt 40 rifle for sale】Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November
NEWTOWN,svt 40 rifle for sale Pa., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:
HSDT
) (TSX:
HSM
) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences:
The Investor Summit Group’s Virtual Fall Summit, which is being held from November 16th - 18th.
Management will present on Tuesday, November 17th at 1:00 p.m. Eastern Time.
Alliance Global Partners’ Virtual Healthcare Symposium, which is being held on November 19th.
Management will participate in virtual 1x1 meetings on Thursday, November 19th. There will be no formal presentation.
The
Sidoti
& Co. Virtual Fall Microcap Conference, which is being held on November 19th.
Management will present on Thursday, November 19th at 9:15 a.m. Eastern Time.
Live audio webcasts of the presentations will be provided under the ‘Events’ section of the Helius Medical Technologies investor relations website at
https://heliusmedical.com/index.php/investor-relations/events/upcoming-events
. Archives of the webcasts will be available for replay following the conference.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS
TM
). For more information, visit
www.heliusmedical.com
.
About the PoNS™ Device and PoNS Treatment™
The Portable Neuromodulation Stimulator (PoNS™) is authorized for sale in Canada as a class II, non-implantable, medical device intended as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from multiple sclerosis (MS), and chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy. The PoNS™ is an investigational medical device in the United States, the European Union (“EU”), and Australia (“AUS”). The device is currently under review for clearance by the FDA. It is also under premarket review by the AUS Therapeutic Goods Administration. PoNS™ is currently not commercially available in the United States, the European Union or Australia.
Investor Relations Contact
:
Westwicke Partners on behalf of Helius Medical Technologies, Inc.
Mike Piccinino, CFA
View comments
-
Recap: eXp World Holdings Q1 EarningsMorning Brief: Congressional leaders attend White House border briefingWhat Should Investors Know About Ascott Residence Trust’s (SGX:A68U) Future?Zimmer: 4Q Earnings SnapshotPetrolympic Announces Closing of Private PlacementHow Karoon Energy Ltd (ASX:KAR) Can Impact Your Portfolio VolatilityCoke's Super Bowl ad mocked: Klingon, Dothraki addedIs Warren Buffett Right to Be Holding UPS?Ramping up COVID-19 testing earlier would have helped the UK, top adviser saysExclusive - Indonesia hopes for additional $10 bilion inflows after S&P upgrade, president says
下一篇:Organic elderberries recalled over possible salmonella contamination
- ·FOREX-Dollar on back foot as recovery optimism persists
- ·Oil producer Afren settles claims against former CEO, COO
- ·Coral Gables Office Building Sells for $2.6 Million
- ·Twin Disc: Fiscal 2Q Earnings Snapshot
- ·Trust Stamp Prepares to Pursue Direct Public Listing on Euronext Growth Market
- ·'We are not robots': Amazon warehouse employees push to unionize
- ·Here’s What Hawaiian Holdings Inc’s (NASDAQ:HA) P/E Ratio Is Telling Us
- ·Disney Infinity Expansion Includes More Marvel and Star Wars
- ·Gilead Sciences Could Be the First to Beat the Coronavirus
- ·Here's Why Disney Will Have a Strong 2019
- ·Trump says China could have hacked Democratic emails
- ·China denies diplomat spied on Japan
- ·Americans have a mix of concern and hope about the economy
- ·How Attorneys and Expert Witnesses Can Effectively Manage Each Other in Domestic Violence Cases
- ·The Latest: NASA spacecraft dashes by world beyond Pluto
- ·BRIEF-Shanghai Environment Plans Waste Incineration Power Project With Investment Of About 721.3 Mln Yuan
- ·5 Stocks With Decent Growth Potential to Watch Ahead
- ·Uffizi Gallery Asks Germany to Return Dutch Masterpiece Nazis Stole in World War II
- ·Going Green Goblin for 'Spider-Man 2': Dane DeHaan gets into character
- ·Is the Dollar in for a Surprise? Nonfarm Payrolls and Wage Growth in Focus
- ·SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, WFC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
- ·Gotham Awards 2019 Live Stream: Watch the Indie Film Awards Online
- ·US STOCKS-Bank, energy stocks lift Wall Street higher in choppy session
- ·5 Physician Memoirs Every Premed Should Read
- ·US$4.75 - That's What Analysts Think Century Aluminum Company (NASDAQ:CENX) Is Worth After These Results
- ·Is AEW UK Long Lease REIT Plc (LON:AEWL) A Healthy REIT?
- ·Gofore Plc: Gofore Plc - Managers' transactions - Virtanen
- ·Does Mediacontech S.p.A. (BIT:MCH) Have A Particularly Volatile Share Price?
- ·Dow futures higher | Jobs report set | Amazon drops 4% after earnings call
- ·Costello Law Group Maryland Lawyers A Law Firm In Baltimore MD Wins Settlement Worth Millions For Their Clients
- ·Exxon CEO sticks to spending targets as oil prices tumble
- ·Oil volatile, ends up 2 percent but demand concerns still weigh
- ·Top Ranked Income Stocks to Buy for January 2nd
- ·A Closer Look At Stride Stapled Group’s (NZSE:SPG) Impressive ROE
- ·Buying a House? 4 Things to Take Off Your Must-Have List Now
- ·BRIEF-China National Chemical Engineering's Unit Signs Methanol-Related Project Worth $1.48 Bln In Russia